Lovenox and Vimovo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lovenox (enoxaparin sodium) and Vimovo (esomeprazole magnesium; naproxen). Common drug interactions include human chorionic gonadotropin increased among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Lovenox and Vimovo. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.

What is Vimovo?

Vimovo has active ingredients of esomeprazole magnesium; naproxen. It is often used in osteoarthritis. eHealthMe is studying from 9,608 Vimovo users. Check the latest studies of Vimovo.



On Jul, 16, 2026

20 people who take Lovenox and Vimovo together, and have interactions are studied.

Lovenox and Vimovo drug interactions.

What are the common drug interactions of Lovenox and Vimovo, by gender? *:

female:

  1. Human chorionic gonadotropin increased
  2. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  3. Pleural infection (infection of membrane of lungs)
  4. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  5. Staphylococcal infection (an infection with staphylococcus bacteria)
  6. Wound infection

male:

  1. Chronic kidney disease
  2. Anaphylactic reaction (serious allergic reaction)
  3. Renal failure (kidney dysfunction)
  4. Renal failure chronic (long lasting kidney dysfunction)
  5. Skin lesion
  6. Skin mass
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Testicular swelling (swelling of testes)
  9. Urinary hesitation (difficulty in beginning the flow of urine)
  10. Abdominal discomfort

What are the common drug interactions of Lovenox and Vimovo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  2. Pleural infection (infection of membrane of lungs)
  3. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  4. Staphylococcal infection (an infection with staphylococcus bacteria)
  5. Wound infection

50-59:

  1. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Human chorionic gonadotropin increased
  4. Chronic kidney disease
  5. Renal failure (kidney dysfunction)

60+:

  1. Abdominal discomfort
  2. Fibromyalgia (a long-term condition which causes pain all over the body)
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. Gastric disorder (disease of stomach)
  5. Sensation of heaviness
  6. Weight increased
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 11 people, 55.00%
  2. Insomnia (sleeplessness): 11 people, 55.00%
  3. High Blood Pressure: 3 people, 15.00%
  4. Pain: 3 people, 15.00%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.00%
  6. High Blood Cholesterol: 3 people, 15.00%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.00%
  8. Oedema (fluid collection in tissue): 2 people, 10.00%
  9. Fluid Overload (too much fluid in the blood): 2 people, 10.00%
  10. Infection: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lovenox and Vimovo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lovenox and Vimovo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lovenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vimovo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lovenox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vimovo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium and esomeprazole magnesium; naproxen (the active ingredients of Lovenox and Vimovo, respectively), and Lovenox and Vimovo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: